Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiac Hypertrophy

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cardiac Hypertrophy in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeMello, D; Lagunoff, D; Ohar, JA; Waller, KS1
Ono, S; Voelkel, NF1
Atakhanov, ShE; Iurenev, AP; Mazaev, AV; Men'shikov, MIu; Tkhostov, EB1

Other Studies

3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cardiac Hypertrophy

ArticleYear
Administration of chronic intravenous platelet-activating factor induces pulmonary arterial atrophy and hypertension in rabbits.
    Laboratory investigation; a journal of technical methods and pathology, 1991, Volume: 65, Issue:4

    Topics: Animals; Atrophy; Cardiomegaly; Hemodynamics; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Platelet Activating Factor; Pulmonary Artery; Rabbits

1991
PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
    Journal of applied physiology (Bethesda, Md. : 1985), 1991, Volume: 71, Issue:6

    Topics: Animals; Azepines; Cardiomegaly; Hypertension, Pulmonary; Lung; Lung Injury; Male; Monocrotaline; Platelet Activating Factor; Rats; Rats, Inbred Strains; Triazoles

1991
[Calcium metabolism in arterial hypertension. I. Myocardial hypertrophy and hormone-dependent increase in Ca2+ levels in the thrombocytes of patients with arterial hypertension].
    Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR, 1988, Volume: 11, Issue:1

    Topics: Adenosine Diphosphate; Adult; Aged; Blood Platelets; Calcium; Cardiomegaly; Humans; Hypercalcemia; Hypertension; In Vitro Techniques; Male; Middle Aged; Models, Cardiovascular; Platelet Activating Factor

1988